• PDA TR 67

PDA TR 67

  • Technical Report No. 67, (TR 67) Exclusion of Objectionable Microorganisms from Nonsterile Pharmaceuticals, Medical Devices, and
  • Report / Survey by Parenteral Drug Association, 10/01/2014
  • Category: PDA

$325.00 $163.00

The purpose of TR 67 is to provide guidance to the nonsterile product manufacturing industry on how to manage the microbial risks associated with manufacturing and storage as well as how to determine what isolates would be deemed an objectionable microorganism in nonsterile products. This document is intended to be globally applicable. When country-specific regulations are cited, they are meant to serve as examples of such and are not binding to the industry stakeholders outside the country's jurisdiction. The absence of a list of objectionable microorganisms from this technical report acknowledges that the manufacturer of the product has all of the variable information, about a product and its intended use, needed to make an informed decision regarding the product's disposition. This belief is consistent with the U.S. cGMP regulations, which assign the responsibility for excluding objectionable microorganisms specifically to the manufacturer.
PDF

All of our standards document are available in PDF (Portable Document Format), an electronic, downloadable format.You will be able to download the file in your account downloads.

Multi-User Access

After purchasing, you have the ability to assign each license to a specific user.

Printable

At any time, you are permitted to make printed copies for your and your members' reference use.

PDA TR 49

PDA TR 49

Technical Report No. 49 (TR 49) Points to Consider for Biotechnology Cleaning Validation..

$163.00 $325.00

PDA TR 50

PDA TR 50

Technical Report No. 50 (TR 50) Alternative Methods for Mycoplasma Testing..

$163.00 $325.00

PDA TR 51

PDA TR 51

Technical Report No. 51 (TR 51) Biological Indicators for Gas and Vapor-Phase Decontamination Proces..

$163.00 $325.00

PDA TR 53

PDA TR 53

Technical Report No. 53 (TR 53) Guidance for Industry: Stability Testing to Support Distribution of ..

$163.00 $325.00